Efficacy and safety of single and double doses of Ivermectin versus 7-day high dose Albendazole for chronic StrongyloidiasisArchived
A prospective, randomized, open study was conducted in which a 7-day course of oral albendazole 800 mg daily was compared with a single dose (200 microgram/kilogram body weight) or double doses, given 2 weeks apart, of ivermectin in Thai patients with chronic strongyloidiasis.
Systematic review and meta-analysis concerning the efficacy and effectiveness of seasonal influenza vaccines – (part 1)Archived
This is an authoritative independent evidence-based review and meta-analysis of the efficacy and effectiveness of influenza vaccines. It confines itself to trials and observational studies where diagnostic tests confirmed influenza infection as the end point.
Lower than usual: early influenza vaccine effectiveness in parts of Europe in season 2011/12Archived
A rapid communication published on April 12th 2012 describes the early results of the annual multicentre case-control study undertaken by the ECDC sponsored I-MOVE consortium whose work is coordinated by an Epiconcept team
Annual influenza vaccine effectiveness meeting 2013 – summary of discussions on obtained results and recommended future research focus
Influenza vaccine experts from thirteen EU countries and invited guests from Canada and the US gathered for three days July 1-3, 2013 in Annecy, France to report and discuss obtained national and pooled multi-country seasonal influenza vaccine effectiveness (VE) obtained in the 2012/2013 season. The meeting was co-organized by ECDC and Epiconcept.
Initial studies on seasonal influenza vaccine effectiveness for 2013/2014
The authors used a test-negative case control design to estimate the 2013/14 influenza vaccine effectiveness (VE) in patients seen with influenza-like illness as outpatients in Spain during December 2013-January 2014.